Aphria (APHA) stock is down after two independent advisory firms recommended that shareholders of Aphria stock vote for the merger between Aphria and Tilray (TLRY), in which Tilray would acquire all of Aphria's outstanding shares. Shares of APHA were down 0.5%, and shares of TLRY were down 1.75% as of 11:54 am on Monday.
Full Answer
Should you hold Aphria (APHA) stock?
Apr 03, 2022 · Their forecasts range from $18.00 to $26.00. On average, they anticipate Aphria's share price to reach $22.25 in the next twelve months. This suggests a possible upside of 44.7% from the stock's current price. View analysts' price targets for Aphria or view top-rated stocks among Wall Street analysts.
Is Aphria efficiently growing its dividend?
Apr 05, 2021 · Why Aphria (APHA) is Down Today. Aphria stock fell after the company announced the results of an independent review by advisory firms Institutional Shareholder Services Inc. ("ISS") and Glass Lewis and Co., LLC ("Glass Lewis"), recommended that Aphria shareholders vote to approve the resolution that would allow Tilray to acquire all the …
Why did Aphria stock drop after Q3 earnings?
Mar 05, 2021 · Pot stocks like CGC, TLRY, APHA and SNDL stock are down today as investors shift risk preferences and eye inflation rates.
How much of Aphria's stock is held by institutions?
9 hours ago · In early afternoon trading today, shares of Microsoft (NASDAQ: MSFT ), Tesla (NASDAQ: TSLA ), Meta Platforms (NASDAQ: FB ), Alphabet (NASDAQ: GOOG, NASDAQ: GOOGL) and Nvidia (NASDAQ: NVDA) are all ...
Why is Aphria stock going down today?
Aphria stock plunged Monday after the Canadian cannabis firm missed expectations for third-quarter sales and its net loss widened. Also falling were shares of Canadian peer Tilray , which plans to merge with Aphria.Apr 12, 2021
What happened to my APHA shares?
Aphria's (NASDAQ:APHA) last trading day is today after it complete its deal with Tilray (NASDAQ:TLRY). The effective date for suspension of the shares is Monday, according to a Nasdaq delisting notice.Apr 30, 2021
Why is APHA so low?
The prime reason for the low inventories in comparison to the expected sales was the completion of their Aphria Diamond facility didn't occur until the end of 2019. The new facility has cultivation capacity of 140,000 kg and brings their total production capacity up to 255,000 kg.Mar 3, 2020
Is Aphria a good stock to buy now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.Mar 11, 2021
Will Tilray go up?
That means that it is possible for Tilray to reach $4 billion in 2024 if its trajectory continues as it has. In other words, it doubles in 2022 to reach $1 billion in revenue. That $1 doubles again in 2023, reaching $2 billion, and then again in 2024 to hit the stated $4 billion goal.Jan 4, 2022
Is APHA now Tilray?
After Tilray's (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction.May 3, 2021
Why is TLRY stock dropping?
Tilray and other pot stocks on major U.S. exchanges are well down from last year. Competition in Canada, continued losses and executive missteps have kept share prices lower. The meme-stocks frenzy that drove some cannabis names higher last year has also faded.
Is Tilray a buy?
Tilray (NASDAQ:TLRY) merged with Aphria in 2021, creating the world's largest cannabis company. As profound as that may sound, TLRY stock has crashed 80% over the past year.Mar 17, 2022
What is the outlook for canopy growth?
Stock Price Forecast The 15 analysts offering 12-month price forecasts for Canopy Growth Corp have a median target of 7.10, with a high estimate of 13.41 and a low estimate of 5.52. The median estimate represents a -0.04% decrease from the last price of 7.10.
Is Aphria buying Tilray?
The deal is expected to close in the second quarter. Under the terms of the proposed deal, Aphria shareholders will receive 0.8381 of a Tilray share of class 2 common stock for each Aphria share owned.May 2, 2021
Is Aphria merging with Tilray?
The two cannabis companies announced in December that they will merge under the Tilray name with Aphria CEO Irwin Simon at the helm and Tilray CEO Brendan Kennedy joining the board. Aphria will lose its name and independent stock symbol on Wednesday.May 3, 2021
Did Tilray buy Aphria?
In December, Aphria (ticker: APHA) and Tilray (TLRY) announced a plan to merge the two businesses. Aphria would effectively conduct a reverse takeover of Tilray, taking its corporate name and its listing on the Nasdaq, with a 62% interest in the combined company.Apr 16, 2021
Is Aphria a buy right now?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently 3 hold ratings and 2...
How were Aphria's earnings last quarter?
Aphria Inc. (NASDAQ:APHA) released its earnings results on Sunday, April, 11th. The company reported ($1.14) earnings per share for the quarter, mi...
What price target have analysts set for APHA?
5 brokerages have issued twelve-month target prices for Aphria's shares. Their forecasts range from $18.00 to $26.00. On average, they expect Aphri...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $5.23M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include STADA Arzneimittel Aktiengesellschaft (STDAF) , Canopy Growth (CGC) , Tilray (TLRY) , USANA H...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV) , Alibaba Grou...
What is Aphria's stock symbol?
Aphria trades on the NASDAQ under the ticker symbol "APHA."
What is Aphria's stock price today?
One share of APHA stock can currently be purchased for approximately $15.38.
How much money does Aphria make?
Aphria has a market capitalization of $4.87 billion and generates $405.96 million in revenue each year. The company earns $-63.21 million in net in...
Aphria's poor third-quarter performance is weighing on both cannabis stocks
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights
What happened
Shares of Aphria ( NASDAQ:APHA) were tanking by 13.2% as of 10:16 a.m. EDT on Monday while shares of Tilray ( NASDAQ:TLRY) were falling by 11.9%. The declines for both stocks came after Aphria reported disappointing fiscal 2021 third-quarter results before the market opened on Monday.
So what
Aphria badly missed analysts' top- and bottom-line estimates for the third quarter. The Canadian cannabis producer's net revenue slipped 6% year over year to 153.6 million Canadian dollars. Aphria posted an adjusted net loss of CA$47.9 million in Q3, much worse than its adjusted net loss of CA$9.8 million in the prior-year period.
Now what
A special meeting of Aphria shareholders is scheduled for Wednesday of this week to vote on the merger with Tilray. It's likely that the deal will be approved. Assuming there aren't any regulatory roadblocks, the transaction is expected to close in the second quarter of 2021.
What happened
Shares of the Canadian pot giant Aphria ( APHA ) are under serious pressure today. The company's stock was down by a whopping 13.4% as of 9:37 a.m. EDT Thursday morning.
So what
Aphria's brain trust placed the blame for this quarterly revenue miss squarely on the coronavirus pandemic.
NASDAQ: APHA
Unfortunately, it's not altogether clear when Aphria's distribution revenue will get back on track. The COVID-19 pandemic is still slowing down in-person visits to doctors' offices and pharmacies across the globe. In other words, investors probably shouldn't expect this key area of Aphria's business to rebound anytime soon.
Now what
Is Aphria's stock a bad-news buy? Like almost all marijuana companies, Aphria is facing an extremely challenging operating environment at the moment. As such, it might be a good idea to watch this small-cap cannabis stock from the safety of the sidelines for the time being.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
There appears to be a lack of professional enthusiasm for the stock following the company's big announcement
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
What happened
Marijuana stock Aphria ( NASDAQ:APHA) declined notably on Monday, shedding almost 5.8% of its value. While investors have already digested last week's news of the company's merger with peer Canadian weedie Tilray ( NASDAQ:TLRY), other factors might be affecting sentiment on the stock.
So what
As is usually the case in notable mergers, several prognosticators tracking Aphria (and Tilray, while we're at it) revised their analyses. It seems that the ones getting more bearish on Aphria are catching the ears of investors.
Now what
Since marijuana stocks keep getting blasted with bad news, investors are probably looking for much more enthusiastic recommendations to support their investment. Given that the Aphria bulls are really only adding a dollar or several at best to their price targets after the merger announcement, those recommendations don't seem to be forthcoming.
